Precision approaches are driving innovation in disease-specific regenerative medicine, where therapies are designed to meet the distinct requirements of conditions like Parkinson’s, type 1 diabetes, and osteoarthritis. By targeting disease mechanisms, researchers employ tailored stem cell lines, responsive scaffolds, and signaling molecules to regenerate affected tissues more effectively. Integration of genetic profiling and cellular engineering enables treatments that address not only structural damage but also underlying pathophysiology. Disease-specific regenerative medicine brings personalized medicine closer to reality by aligning molecular pathology with regenerative tools. This targeted approach reduces risks of immune rejection and improves therapeutic efficacy, especially in chronic and degenerative conditions with limited treatment options.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cells for human disease modelling and potential for tissue repair
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Personalized and Precision Medicine (PPM): A unique healthcare model via pathology-related modelling and bi-odesign-inspired translational applications for the next gen-eration of human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation